141 filings
Page 3 of 8
8-K
j3dkq
26 Sep 18
Entry into a Material Definitive Agreement
12:00am
8-K
n1rh3gz9
31 Jul 18
Entry into a Material Definitive Agreement
4:52pm
8-K/A
2v6j2azr
2 Jul 18
Index to Financial Statements
4:05pm
8-K
a1ebdzp
16 May 18
Regulation FD Disclosure
3:12pm
8-K
qchxb3
15 May 18
Departure of Directors or Certain Officers
12:00am
8-K
db3ms8kyyhboayj
14 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
iiw8zph cq60441
30 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
e9i91me
29 Dec 17
Cost Associated with Exit or Disposal Activities
12:00am
8-K
ys8djmnnc72n3
26 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
36y vnsga5
6 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
ykg3y jfv
21 Apr 17
Departure of Directors or Certain Officers
12:00am
8-K/A
w71vs0xh
31 Mar 17
Financial Statements and Exhibits
12:00am
8-K
1dawy6jn2bm6 x1ne
13 Mar 17
OncBioMune Acquires Vitel Laboratorios, Gains Two Revenue Generating Drugs, Robust Pipeline and Extensive Distribution Network
12:00am
8-K
78e2o
28 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
a3abkjdnzf86
3 Nov 16
Regulation FD Disclosure
12:00am
8-K
uqknrwkcc1
14 Sep 16
Regulation FD Disclosure
12:00am
8-K
8w910
26 Aug 16
Financial Statements and Exhibits
12:00am
8-K
igvdy40g5 yx
5 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
wsvd5h5 qehzrzoa
22 Jan 16
OncBioMune Receives Notice of Allowance for Patent Covering New Targeted Cancer Treatments
12:00am
8-K
4gznbs
5 Jan 16
Departure of Directors or Certain Officers
12:00am